Latest Insider Transactions at Scholar Rock Holding Corp (SRRK)
This section provides a real-time view of insider transactions for Scholar Rock Holding Corp (SRRK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Scholar Rock Holding Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Scholar Rock Holding Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2024
|
Joshua Reed |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+50.0%
|
-
|
|
Jun 27
2024
|
Akshay Vaishnaw |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+37.03%
|
-
|
|
Jun 27
2024
|
Jeffrey S. Flier |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+37.49%
|
-
|
|
Jun 27
2024
|
Michael Gilman |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+50.0%
|
-
|
|
Jun 27
2024
|
Richard Brudnick |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+50.0%
|
-
|
|
Jun 27
2024
|
David Hallal |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+4.25%
|
-
|
|
Jun 27
2024
|
Srinivas Akkaraju |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+50.0%
|
-
|
|
Jun 17
2024
|
Caryn Parlavecchio CHRO |
SELL
Open market or private sale
|
Direct |
4,305
-2.73%
|
$34,440
$8.98 P/Share
|
|
Jun 17
2024
|
Mo Qatanani CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,315
-1.57%
|
$18,520
$8.98 P/Share
|
|
Jun 17
2024
|
Junlin Ho GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
4,695
-2.25%
|
$37,560
$8.98 P/Share
|
|
Jun 17
2024
|
Edward H Myles COO & CFO |
SELL
Open market or private sale
|
Direct |
9,458
-4.48%
|
$75,664
$8.98 P/Share
|
|
May 09
2024
|
Amir Nashat |
BUY
Other acquisition or disposition
|
Direct |
13,133
+12.71%
|
-
|
|
May 09
2024
|
Amir Nashat |
SELL
Other acquisition or disposition
|
Indirect |
598,533
-61.12%
|
-
|
|
May 09
2024
|
Amir Nashat |
BUY
Other acquisition or disposition
|
Indirect |
98,855
+39.33%
|
-
|
|
Apr 09
2024
|
Katie Peng |
BUY
Grant, award, or other acquisition
|
Direct |
26,825
+50.0%
|
-
|
|
Feb 16
2024
|
Edward H Myles COO & CFO |
SELL
Open market or private sale
|
Direct |
4,744
-2.2%
|
$71,160
$15.74 P/Share
|
|
Feb 16
2024
|
Mo Qatanani CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,512
-1.68%
|
$37,680
$15.74 P/Share
|
|
Feb 16
2024
|
Caryn Parlavecchio CHRO |
SELL
Open market or private sale
|
Direct |
3,751
-2.32%
|
$56,265
$15.74 P/Share
|
|
Feb 16
2024
|
Jay T. Backstrom CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
11,614
-3.19%
|
$174,210
$15.74 P/Share
|
|
Feb 16
2024
|
Junlin Ho GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
3,489
-1.64%
|
$52,335
$15.74 P/Share
|
|
Feb 12
2024
|
Jing L. Marantz CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
72,855
+50.0%
|
-
|
|
Feb 12
2024
|
Jay T. Backstrom CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
214,285
+37.04%
|
-
|
|
Feb 12
2024
|
Caryn Parlavecchio CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
47,145
+22.6%
|
-
|
|
Feb 12
2024
|
Mo Qatanani CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
70,715
+32.11%
|
-
|
|
Feb 12
2024
|
Tracey Sacco Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,285
+50.0%
|
-
|
|
Feb 12
2024
|
Junlin Ho GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
57,855
+21.42%
|
-
|
|
Feb 12
2024
|
Edward H Myles COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
53,570
+19.89%
|
-
|
|
Jan 16
2024
|
Caryn Parlavecchio CHRO |
SELL
Open market or private sale
|
Direct |
2,849
-2.43%
|
$42,735
$15.93 P/Share
|
|
Jan 16
2024
|
Mo Qatanani CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,002
-2.48%
|
$30,030
$15.93 P/Share
|
|
Jan 16
2024
|
Junlin Ho GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
4,186
-2.64%
|
$62,790
$15.93 P/Share
|
|
Jan 16
2024
|
Edward H Myles COO & CFO |
SELL
Open market or private sale
|
Direct |
6,634
-3.93%
|
$99,510
$15.93 P/Share
|
|
Dec 29
2023
|
Edward H Myles COO & CFO |
SELL
Open market or private sale
|
Direct |
12,459
-3.44%
|
$236,721
$19.17 P/Share
|
|
Dec 29
2023
|
Edward H Myles COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,459
+6.43%
|
$49,836
$4.86 P/Share
|
|
Dec 27
2023
|
Amir Nashat |
SELL
Bona fide gift
|
Direct |
21,333
-45.55%
|
-
|
|
Dec 21
2023
|
Kristina Burow |
BUY
Other acquisition or disposition
|
Direct |
5,339
+50.0%
|
-
|
|
Dec 21
2023
|
Kristina Burow |
SELL
Other acquisition or disposition
|
Indirect |
291,906
-11.07%
|
-
|
|
Dec 14
2023
|
Mo Qatanani CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
24,662
-23.38%
|
$443,916
$18.18 P/Share
|
|
Dec 14
2023
|
Mo Qatanani CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,437
+7.41%
|
$84,370
$10.0 P/Share
|
|
Dec 13
2023
|
Amir Nashat |
BUY
Other acquisition or disposition
|
Direct |
26,265
+18.03%
|
-
|
|
Dec 13
2023
|
Amir Nashat |
SELL
Other acquisition or disposition
|
Indirect |
1,197,068
-65.4%
|
-
|
|
Dec 13
2023
|
Amir Nashat |
BUY
Other acquisition or disposition
|
Indirect |
197,711
+45.31%
|
-
|
|
Dec 07
2023
|
Edward H Myles COO & CFO |
SELL
Open market or private sale
|
Direct |
24,914
-12.86%
|
$423,538
$17.53 P/Share
|
|
Dec 07
2023
|
Edward H Myles COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,914
+11.4%
|
$99,656
$4.86 P/Share
|
|
Nov 20
2023
|
Amir Nashat |
BUY
Other acquisition or disposition
|
Direct |
13,133
+19.56%
|
-
|
|
Nov 20
2023
|
Amir Nashat |
SELL
Other acquisition or disposition
|
Indirect |
598,537
-56.67%
|
-
|
|
Nov 20
2023
|
Amir Nashat |
BUY
Other acquisition or disposition
|
Indirect |
98,859
+46.33%
|
-
|
|
Nov 02
2023
|
Edward H Myles COO & CFO |
SELL
Open market or private sale
|
Direct |
35,007
-17.18%
|
$420,084
$12.51 P/Share
|
|
Oct 16
2023
|
Samsara Bio Capital Gp, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,189,781
+24.39%
|
$13,138,686
$6.85 P/Share
|
|
Oct 16
2023
|
Srinivas Akkaraju |
BUY
Open market or private purchase
|
Indirect |
2,189,781
+24.39%
|
$13,138,686
$6.85 P/Share
|
|
Oct 12
2023
|
Invus Public Equities, L.P. |
BUY
Open market or private purchase
|
Direct |
2,199,931
+8.19%
|
$15,399,517
$7.7 P/Share
|